Immune Cell Signals in Allergic Asthma Patients
Studies immune cell signals that may distinguish allergic asthma from non-allergic disease in adults.
Plain-language title generated from the registry record
Registry title: Innate Immunity in Allergic Asthma
Key facts
- Where
- Orlando, United StatesSee the site
Where in United States
- University of Central FloridaOrlando, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Central Florida
- Trial code
- NCT06068335
- Record updated
- 6 December 2024
- Original description
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.Read full original descriptionShow less
Innate Immunity in Allergic Asthma
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
Inclusion: Participants must be at least 18 years of age; no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.
Exclusion: Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded; Pregnant women and prisoners will be excluded from the study.